跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
袁 維謙
助理教授
腫瘤惡化卓越研究中心
生命科學系暨基因體科學研究所
電話
02-2826-7232
電子郵件
wcyuan
nycu.edu
tw
h-index
h10-index
h5-index
1049
引文
10
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
776
引文
7
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
288
引文
3
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2010
2020
每年研究成果
概覽
指紋
網路
研究成果
(10)
類似的個人檔案
(6)
指紋
查看啟用 Wei-Chien Yuan 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Adaptor
46%
Apologizing
33%
Barcoding
22%
Cas9 Protein
66%
Cell Biology
33%
Cell State
16%
Cell-to-cell
33%
Coronin
33%
CRISPR Array
33%
Cullin3
100%
Cyclin-dependent Kinase 9 (CDK9)
33%
Death-associated Protein Kinase 1 (DAPK1)
33%
E3 Ubiquitin Ligase
33%
Equal Sign
33%
Exocytosis
33%
Gene Expression Profile
66%
Hematopoietic Stem Cells
22%
HIF-1 Signaling Pathway
33%
Hippo Pathway
56%
Human Malignancies
33%
Hypoxia-inducible factor-1α (HIF-1α)
33%
Inconvenience
33%
Interferon Response
33%
Interferon-α (IFN-α)
19%
Intestinal Stem Cells
33%
KLHL20
100%
Lineage Tracing
33%
Liver Cancer
33%
Mediator Complex
16%
Metastatic Colorectal Cancer (mCRC)
33%
NUAK2
33%
Overgrowth
23%
Pause Release
33%
Pin1
16%
Polyubiquitination
35%
Production Errors
33%
Promyelocytic Leukemia
33%
Prostate Cancer Progression
33%
Protein Trafficking
33%
RAB37
33%
Small GTPase
33%
Stem Cell Activation
27%
Stem Cell State
33%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
33%
Trans-Golgi Network
28%
Tumor Metastasis
33%
Tumorigenesis
61%
Ubiquitin Ligase
33%
Ubiquitination
80%
Wound Healing
16%
Biochemistry, Genetics and Molecular Biology
Actin
9%
Actin Polymerization
16%
Angiogenesis
9%
Cancer Cell
33%
Carcinogenesis
61%
Cell Activity
19%
Cell Fate
16%
Cell Proliferation
16%
Cell Selection
8%
Coronin
33%
CRISPR
33%
CRISPR/Cas9
33%
Cullin
66%
Downregulation
9%
Enhancer Region
33%
Exocytosis
33%
Gelatinase B
11%
Gene Expression
33%
Gene Linkage
9%
Genetics
11%
Hematopoietic Cell
16%
Hippo Signaling Pathway
33%
Interferon
33%
Kinase
11%
Mediator
30%
Mediator Complex
11%
Metalloprotease Inhibitor
33%
Metastasis Suppressor
11%
MMP9
11%
Phosphotransferase
11%
Polymerase
11%
Polymorphonuclear Cell
35%
Promoter Region
11%
Protein Kinases
33%
Protein Targeting
33%
Regulatory Element
11%
Reprogramming
38%
Signal Transduction
27%
Small GTPase
33%
Stem Cell
44%
Target Tissue
33%
Tissue Growth
11%
Transcription
22%
Tumor Hypoxia
11%
Tumor Progression
15%
Ubiquitin
14%
Ubiquitin Ligase
33%
Ubiquitin-Conjugating Enzyme
33%
Ubiquitination
80%
Wound Healing
16%
Pharmacology, Toxicology and Pharmaceutical Science
Actin
11%
Cancer Growth
33%
Carcinogenesis
16%
Combination Therapy
8%
Cullin
33%
Death Associated Protein Kinase
33%
Disease Exacerbation
16%
Drug Resistance
8%
Gelatinase B
11%
Glycoprotein
5%
Guanosine Triphosphatase
33%
Hepatomegaly
11%
Hypoxia
33%
Interferon
33%
Ligase
7%
Liver Cancer
33%
Lung Cancer
5%
Malignant Neoplasm
48%
Metastasis
33%
Multiple Cancer
12%
Neoplasm
28%
Promyelocytic Leukemia
33%
Promyelocytic Leukemia Protein
8%
Prostate Cancer
33%
Tissue Inhibitor of Metalloproteinase 1
33%
Tumor Growth
20%
Tumor Suppressor Protein
8%
Ubiquitin Protein Ligase
33%
